CCMDBIO | CCM DUOPHARMA BIOTECH BHD

CCMDBIO | CCM DUOPHARMA BIOTECH BHD

2.85 (-0.35%)
Last updated: 17:00
Fundamental   6.0  
Technical   5.5  
Total Score   11.5  

 Insti+ 
CCMDBIO | CCM DUOPHARMA BIOTECH BHD
Stock charts by TradingView
Last Price 2.85
Trailing PE (Sector Median: 17.5) 20.1
EV/EBITDA (Sector Median: 11.9) 10.9
PEG -7.96
Sharpe Ratio (3-yrs) 0.39
ROE 5.93 %
ROIC 8.08 %
Altman Z 3.6
Beaver 0.18
Current Ratio 2.7
Revenue QoQ 43.68 %
Profit QoQ 79.86 %
Profit YoY 19.18 %
NTAPS QoQ 4.94 %
Profit Margin (Sector Median: 4.9) 9.43 %
Debt-Equity (DE) Ratio 0.5
Dividend Per Share (DPS) 6.34 sen
Dividend Yield (DY) 2.22 %
FCF Yield -3.0 %
Net Current Asset Value (NCAV) 0.495

Support & Resistance

ATR Trailing Stop: 2.85

Support
Close
Resistance
Price 2.39 2.4 2.82 2.83 2.85 2.85 2.85 2.86 2.88 2.89 2.9
Volume (M) 2.6 12.7 0.6 5.0 4.6 4.6 1.8 4.4 2.2 0.8

Risk Reward Ratio: 61.9
*Highlighted column shows significant volume at the support or resistance area.


Technical Trend


Moving Average Trend
Volume Trend


Trading Signalsbeta - CCMDBIO

Based on iSaham Screeners

Moving Average (Short Term) BUY
Moving Average (Mid Term) BUY
Moving Average (Long Term) BUY
Ichimoku Kumo BUY
Bollinger Band -
RSI BUY
Stochastic BUY
Heikin-Ashi SELL
MACD BUY (Above 0)
Solid MA Trend BUY
SAT SELL
Sector Trend (Overall) HOLD
Sector Trend (Short Term) BUY
Institutional Holdings BUY
Beat The Insti -
Magic Formula -
Better Than ASB -
52-Week High -
BTST -
T+ -
Candlestick -
Chart Pattern -

Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.

Fundamental Trend - CCMDBIO

Based on iSaham FCON Method
FCON Ratio: 0.64

Profit Indicator

Revenue Indicator


Fair Value

iSaham Fair Value: 1.23

Discounted Cash Flow (DCF)5.0% Growth 1.23
Discounted Cash Flow (DCF)-2.5% Growth 0.85
Relative Valuation 2.48
Graham Formula 1.08
Graham Number 2.31
Net Tangible Asset MA 1.66


Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 138.2
Expected Revenue (M) 1465.56
Expected Growth (%) 22.0


Summary

Market Cap: 814 M.

Number of Shares: 285 M.

Share Weight: Light.

CCM Duopharma Biotech Berhad, an investment holding company, is engaged in the manufacture, distribution, import, and export of pharmaceutical products and medicines in Malaysia. It offers various over the-counter products, including oral antibiotics, cough syrups, analgesic/anti-pyretics, anti-bacterial mouthwash, children's vitamins, haemodialysis solutions, dental cartridges, and eye drop preparations. The company exports its products to various countries, including Vietnam, Ethiopia, Sudan, Southeast Asia, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, Republic of Yemen, Singapore, and Hong Kong. Founded in 1979, the company is based in Klang, Malaysia. CCM Duopharma Biotech Berhad is a subsidiary of CCM Marketing Sdn. Bhd.

Code: 7148

Website: http://www.duopharma.com.my/

Related Links: Bursa | i3 Price Target | Annual Report | Announcement

Pivot Point

S2
S1
P
R1
R2
Daily 2.82 2.84 2.84 2.86 2.86
Weekly 2.78 2.81 2.86 2.89 2.94